Replica company

A biotech company wants to take human DNA and create artificial embryos that could be used to harvest organs for medical transplants

Getty Images

  • An Israeli company wants to reproduce a successful experiment on mouse embryos with human cells.

  • The company, Renewal Bio, wants to use technology to make “humanity healthier and younger”.

  • The use of synthetic human embryos has raised ethical concerns within the scientific community.

An Israel-based biotech company wants to replicate a recent experiment that successfully created an artificial mouse embryo from stem cells – but this time with human cells.

According to a paper published in the journal Cell on Aug. 1, scientists from Weizmann’s Department of Molecular Genetics grew “synthetic mouse embryos” in a jar without using sperm, eggs or uterus. It was the first time the process had been successful. done, reported Insider’s Marianne Guenot.

The replica embryos could not develop into fully formed mice and were therefore not “real”, Jacob Hanna, who led the experiment, told the Guardian. However, scientists have observed that synthetic embryos have a beating heart, blood flow, the beginnings of a brain, a neural tube, and an intestinal tract.

Hanna told MIT Technology Review after the success of the mouse experiment that he was working to replicate the results with human cells, including his own.

“The embryo is the best organ building machine and the best 3D bio-printer – we tried to mimic what it does,” Hanna said in a statement.

Other experts say it will take a lot more research before synthetic human embryos are within reach.

Renewal Bio, the Israeli company founded by Hanna, wants to use this science for organ tissue transplants that could solve infertility, genetic diseases and problems related to old age.

For example, the MIT Technology Review reported that blood cells from the embryo could potentially be used to help boost immune-compromised systems.

Renewal Bio believes that some of the world’s most pressing issues are “falling birth rates and rapidly aging populations,” according to the company’s website.

“To solve these complex and complex problems, Renewal Bio aims to make humanity younger and healthier by harnessing the power of new stem cell technology,” the website says.

Omri Amirav-Drory, interim CEO of Renewal Bio, told MIT Technology Review that the company didn’t want to “promise too much” or scare people off with the potential technology, but that Hanna’s experience was ” unbelievable”.

The use of human embryo clones for research has frequently raised ethical concerns within the scientific community, including the potential that synthetic embryos may experience pain or tenderness, according to a 2017 article published in eLife magazine.

Hanna told the MIT Technology Review that he could potentially circumvent these ethical concerns by creating synthetic human embryos without “lungs, hearts, or brains.”

Read the original article on Business Insider